Alexander Azoy has sold RCUS and made no open-market buys since Dec 2025

Alexander Azoy is the Chief Accounting Officer at Arcus Biosciences, Inc. (RCUS), a role he has held since October 2020, and was formally appointed as Principal Accounting Officer by the Board on March 9, 2023.( In this position, he also serves as VP of Finance, overseeing financial management, audit committees, compliance, and regulatory requirements for the biotechnology company.(

Azoy brings extensive experience in finance and accounting, with prior roles including VP of Finance at UNITY Biotechnology, CFO at Sienna Biopharmaceuticals, and Vice President of Accounting at Smart & Final.( His career includes positions at EY, Warner Bros. Entertainment Group, and began at TLJ Financial Management Inc., focusing on technical accounting and strategic oversight across life sciences, consumer products, and media sectors.( He holds a Bachelor of Science in Accounting from California State University, Northridge.( As a corporate insider, Azoy has engaged in multiple share sales of RCUS stock, including 1,579 shares on September 5, 2025, under a 10b5-1 plan, and others in 2024-2025, retaining significant holdings valued at approximately $415,743 as of early 2026.(

Written by Perplexity from public sources.